Aging is a major concern in developing societies, which are characterized by an escalation in the aged population as well as in the prevalence of many chronic diseases associated with this inevitable biological process. There is a strong desire to delay aging and increase the length of disease-free life. For that purpose there is a need to better understand the human aging process, as the mechanisms that regulate aging remain largely unknown. The adult stem cell reservoir, which not only declines in size with age, but also particularly handicaps those regenerative tissues repopulated by this reservoir of stem cells, deserves special consideration. We have recently reported the characterization of a new stem cell human experimental model, based on posttranslational defects of the LMNA gene expression associated with progeroid syndromes. In this work, we summarize the necessity of developing reliable human experimental models for the study of human stem cell aging, and outline the phenotypes exhibited by this new experimental human aging model due to accumulation of an aberrant LMNA product with detrimental repercussions to in vivo functionality. This in vitro model has been fundamental for the identification of a novel role of a known transcription factor in human stem cell aging, demonstrating the potential of the model as a tool to unravel the molecular mechanisms governing human aging.
Aging is a major concern in developing societies, which are characterized by an escalation in the aged population as well as in the prevalence of many chronic diseases associated with this inevitable biological process. There is a strong desire to delay aging and increase the length of disease-free life. For that purpose there is a need to better understand the human aging process, as the mechanisms that regulate aging remain largely unknown. The adult stem cell reservoir, which not only declines in size with age, but also particularly handicaps those regenerative tissues repopulated by this reservoir of stem cells, deserves special consideration. We have recently reported the characterization of a new stem cell human experimental model, based on posttranslational defects of the LMNA gene expression associated with progeroid syndromes. In this work, we summarize the necessity of developing reliable human experimental models for the study of human stem cell aging, and outline the phenotypes exhibited by this new experimental human aging model due to accumulation of an aberrant LMNA product with detrimental repercussions to in vivo functionality. This in vitro model has been fundamental for the identification of a novel role of a known transcription factor in human stem cell aging, demonstrating the potential of the model as a tool to unravel the molecular mechanisms governing human aging. Aging is becoming a highly researched field due to an increase in the aged population: the world population of people 60 years or older is expected to rise to approximately 22% of the total population by 2050 [1] . Currently, in developed countries where the human life expectancy is approximately 78-85 years, it has been estimated that individuals suffer aging associated diseases during their last 20 years. Healthy aging has, therefore, become a major socioeconomic challenge in developed societies, which are characterized by decreased birth rates and increased aging populations. Objectives in aging research include not only extending longevity, but most importantly improving human health during aging, thereby increasing disease free time.
Currently the aging process is far from being completely understood; however, knowledge concerning the molecular basis of aging has significantly increased in recent years due to studies carried out in nematodes, flies and murine systems.
Nevertheless, the elucidation of the molecular basis of human aging would be best unraveled in biological systems which avoid the numerous and substantial interspecies differences which have limited the successful extrapolation of a number of conclusions to the human aging process. For example, significantly greater telomere lengths in mice (40-60 kb) compared to human telomeres (5-15 kb) is likely related to the differing senescence mechanisms in mice and humans [2] . Thus, there is a clear need of human experimental models to study and elucidate the molecular basis of the
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complex processes of human aging [3] .
Progeroid syndromes are human diseases in which several features of human aging are prematurely developed, resulting in a considerable reduction of the lifespan of patients. These progeroid syndromes have proven to be valuable tools to gain insight into the molecular mechanism that rule human aging [4] . Among the genes associated with progeroid diseases, LMNA is responsible for at least 16 different diseases called laminopathies [5] . The LMNA gene encodes A-type lamins (lamins A and C), which in conjunction with B-type lamins are the principal components of the intermediate filament network forming the nuclear lamina situated on the inside of the nuclear envelope. Most of the laminopathies have a genetic origin such as Hutchison-Gilford progeria syndrome (HGPS), a disease which is characterized by a single point mutation in LMNA; however, other progeroid syndromes are acquired, such as the lipodystrophic syndrome associated with the use of human immunodeficiency virus (HIV) protease inhibitors which interfere with the correct processing of lamina [6] . HGPS and LMNA associated lipodystrophies are characterized by the accumulation of the aberrant LMNA gene products: progerin and prelamin A, respectively. These pathological accumulations cause abnormal nuclear structure and alter downstream biological functions preceding the premature aging phenotypes [7] . The link with physiological aging has acquired special relevance by the demonstration of the accumulation of progerin [8] , and more recently prelamin A accumulation [9] , in normally aging cells. Human experimental models based on progeroid syndromes have the advantage that unlike the many decades needed to realize normal human physiological aging, only days or weeks are required before cell aging and its associated phenotypes are present in progeroid cells in culture conditions. Adult stem cells, found in mammalian organs, are crucial for tissue generation, maintenance and repair, replacing cells lost throughout an individual's adult life. However, this cellular reservoir is affected by aging causing a decline in stem cell number and function [10] . Thus, age associated alterations in the function of stem cells may participate in some diseases of aging, principally in regenerative tissues that are nourished/repopulated by the stem cells. In fact, stem cell exhaustion is itself one of the most evident features of aging [11] . The identification and characterization of the molecular basis regulating stem cell aging would provide critical information to understanding how certain tissues are able to maintain regenerative capacity throughout adult life and how that capacity diminishes with age [12] . Recent studies have demonstrated the capacity of certain factors obtained from the blood of young animals to improve the functionality of aged stem cells. Although these experiments have been carried out in mice, the possibility that such procedures could be extrapolated to humans has generated high expectations [13] . Because it is unknown how the timing and commitment of stem cell differentiation occurs, human stem cell aging models are postulated to be essential tools to unravel these mechanisms and how they are affected by the aging process. They could also be extremely useful in studying the similarities and differences of these mechanisms with respect to regulating non stem cell aging.
LMNA gene alterations mainly affect mesoderm-derived tissue (i.e.: muscle and adipocytes). Human experimental models based on mesenchymal stem cells have been valuable tools to study progeroid syndromes; i.e: to explore the consequences of the progerin accumulation responsible for HGPS. The introduction of progerin into hMSCs results in several defects that resemble those observed in cells from HGPS patients showing adult stem cell dysfunction [14] . A human Hutchinson Gilford Progeria model based on induced pluripotent stem cells (iPSCs) proposed that adult stem cells are negatively affected by progerin toxicity in addition to the reduction in stem cell numbers caused by the replacement of lost mesenchymal tissues [15] .
We have previously developed a laminopathy human experimental model based on pharmacological treatment of mesenchymal stem cells, a procedure which results in the accumulation of prelamin A. This LMNA-lipodystrophy human experimental model recapitulates some of the phenotypes observed in HGPS and LMNA-lipodystrophy patient fibroblasts, as well as in murine models [16] . One of the phenotypes presented by this model is increased senescence resulting in decreased proliferation capacity, a well-defined aging feature. We have challenged the prelamin A-accumulating hMSCs (prelamin A-hMSCs) to attempt to replicate other phenotypes which have been identified as hallmarks of aging brilliantly defined and categorized by López-Otí n and collaborators [11] . We have demonstrated that the prelamin A-hMSCs exhibit a precise premature aging phenotype characterized by telomere shortening, defective proteostasis, increased genomic instability, senescence, ROS production and susceptibility to stress. These characteristics ultimately result in declined functional capability in vivo [17] . The relevance of this premature aging model has been made evident by its critical role in the identification of a previously unknown function of the Oct-1 transcription factor in human mesenchymal stem cell aging. This result reinforces the hypothesis that prelamin A accumulation causes remodeling of the finely tuned network of the nuclear lamina, thereby possibly altering the binding of a diverse set of factors to the nuclear lamina and resulting in the modification of the activity of certain transcription factors either directly or indirectly [18] . These results highlight the potential of this human experimental aging model as an invaluable platform for elucidating the molecular mechanisms of human adult stem cell aging, as well as suggesting new avenues of research into therapeutic strategies to reduce or ameliorate aging phenotypes and the diseases associated with stem cell aging.
